# A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu

> **NCT05249244** · — · UNKNOWN · sponsor: **China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05249244
- **Lead sponsor:** China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05249244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05249244, "A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05249244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*